Skip to main content
. 2022 Jun 26;9(7):278. doi: 10.3390/bioengineering9070278

Table 2.

Cytotoxicity assay of the prepared magnetic scaffolds as a function of time (day 1–day 7). Tests included micro- and nano-meter sized Fe3O4 at different ratios to PCL.

Days 1 2 3 4 5 6 7
Fe3O4 free 0.98 ± 0.04 0.97 ± 0.02 0.98 ± 0.01 0.88 ± 0.09 1.10 ± 0.04 1.09 ± 0.05 1.04 ± 0.02
µm Fe3O4 Scaffold 5% 0.92 ± 0.03 0.95 ± 0.05 0.90 ± 0.04 0.82 ± 0.05 0.94 ± 0.05 0.99 ± 0.10 0.94 ± 0.05
10% 0.94 ± 0.04 0.94 ± 0.03 0.95 ± 0.02 0.88 ± 0.03 1.01 ± 0.02 0.97 ± 0.04 0.95 ± 0.04
20% 1.03 ± 0.04 0.98 ± 0.05 0.90 ± 0.05 0.81 ± 0.04 0.99 ± 0.05 0.97 ± 0.05 0.95 ± 0.05
40% 0.97 ± 0.05 0.90 ± 0.04 0.89 ± 0.05 0.80 ± 0.08 0.94 ± 0.04 0.94 ± 0.06 0.95 ± 0.05
nm Fe3O4 Scaffold 5% 1.01 ± 0.07 0.96 ± 0.05 0.94 ± 0.05 0.81 ± 0.05 1.05 ± 0.04 1.08 ± 0.04 1.02 ± 0.02
10% 0.99 ± 0.05 0.97 ± 0.06 0.90 ± 0.06 0.79 ± 0.06 0.97 ± 0.05 0.98 ± 0.05 1.02 ± 0.05
20% 0.92 ± 0.03 0.88 ± 0.05 0.87 ± 0.05 0.79 ± 0.05 0.96 ± 0.08 0.97 ± 0.04 1.00 ± 0.03
40% 0.92 ± 0.05 0.89 ± 0.01 0.85 ± 0.03 0.81 ± 0.03 0.95 ± 0.05 0.97 ± 0.05 0.95 ± 0.06